VERTIGIS
10.3.2022 07:02:11 CET | Business Wire | Pressemeddelelse
VertigGIS, en førende udbyder og softwareudvikler af geografiske informationssystemer (GIS), har gennemført erhvervelsen af 100 % af EDP Consult AB, en etableret leverandør af software og services med base i Staffanstorp i Sverige.
Der er multimedier i denne pressemeddelelse. Se hele meddelelsen her: https://www.businesswire.com/news/home/20220309005032/da/
VertiGIS støttes af et globalt investeringsselskab med fokus på teknologi, Battery Ventures, der i 2017 begyndte at erhverve softwarevirksomheder inden for GIS- og positionsteknologi under sit varemærke.
EDP, der er bedst kendt for produkterne EDP Future, EDP Mobile og EDP Vision, udvikler og leverer software til svenske kommuner. Virksomhedens teknologi håndterer specifikt kundens udfordringer inden for vand og affald, fjernvarme, leje og generel fakturering samt sagsovervågning og dokumentstyring for alle dele af den offentlige administration, offentlige styrelser og virksomheder.
EDP's stifter og administrerende direktør Mikael Nyquist forklarer: "Jeg er stolt over det, som mine EDP-kolleger har opnået i løbet af de seneste 39 år, og jeg er spændt på at se, hvordan vi vil udvikle os og tilbyde vores kunder ny værdi som en del af VertiGIS."
EDP bliver partner i VertiGIS' eksisterende virksomhed inden for den offentlige sektor, der har årtiers dokumenteret ekspertise i at hjælpe kommuner med at løse lignende udfordringer på dets respektive markeder.
"EDP's kundeorienterede tilgang til digitalisering af processer og løsning af udfordringer med positionsteknologi passer godt til vores," tilføjer Richard Wiegmann, President & CEO for VertigGIS. "Vi er glade for at få EDP med i VertiGIS og ser frem til at være med til at tilbyde deres ekspertise til nye kunder over hele verden, samtidig med at vi finder muligheder for eksisterende VertiGIS-teknologi på det nordiske marked."
EDP's produktlinjer slås sammen med VertiGIS’ løsninger til offentlig sektor- og arealforvaltning, forsyning og energi, telekommunikation og infrastruktur- og ejendomsadministration, der betjener mere end 5.200 kunder over hele verden.
Om VertiGIS:
VertiGIS er førende udbyder og softwareudvikler inden for geografiske informationssystemer (GIS). Virksomheden har fokus på udvikling af softwareløsninger og tjenester, der hjælper kunder inden for forsyning og energi, arealforvaltning, den offentlige sektor, telekommunikation samt branchekunder med at koble deres forretningsprocesser sammen med positionsteknologi. Produktporteføljen fra VertiGIS anvendes af tusindvis af kunder og millioner af slutbrugere i over 50 lande og er designet til at forbedre egenskaberne ved førende kortlægningssoftware, især ESRI's ArcGIS®. De vigtigste produktmærker omfatter: VertiGIS Studio, UT for ArcGIS®, 3A produktlinjen, GEONIS, ConnectMaster™, M4® Solutions, GeoOffice, WebOffice, ProOffice og EDP-produkterne Future, Mobile og Vision. Få mere at vide påwww.vertigis.com .
Om EDP:
Mere end 90 % af Sveriges kommuner driver deres daglige virksomhed ved hjælp af software fra EDP. Ved at arbejde tæt sammen med svenske kommuner, statslige styrelser og store virksomheder udvikler EDP sammenhængende, funktionelle og tidsbesparende IT-løsninger til den offentlige sektor. EDP-software anvendes på flere forskellige forretningsområder, f.eks. affaldshåndtering og styring af byggetilladelser, og bidrager til et velfungerende digitalt samfund, der er tilgængeligt for alle. Få mere at vide på www.edp.se .
Om Battery Ventures:
Battery bidrager med exceptionelle stiftere og ledelsesteams og udvikler kategoridefinerende virksomheder på markeder såsom software og services, virksomhedsinfrastruktur, onlinemarkeder, sundheds-IT og industriteknologi. Virksomheden blev stiftet i 1983 og støtter virksomheder på alle stadier, lige fra seed-kapital og tidligt i processen til vækst og overtagelse, og investerer globalt fra kontorer i Boston, San Francisco og Menlo Park, Californien, Herzliya, Israel; London og New York. Følg firmaet på Twitter @BatteryVentures, besøg vores hjemmeside på www.battery.com , og se en komplet liste over selskaberne i Batterys portefølje her .
Originalsprogsudgaven af denne bekendtgørelse er den officielle, autoriserede version. Oversættelserne er kun tænkt som en hjælp og bør sammenholdes med kildesprogsteksten, der som den eneste er juridisk bindende.
Se kildeudgaven på businesswire.com: https://www.businesswire.com/news/home/20220309005032/da/
Link:
Information om Business Wire
Følg pressemeddelelser fra Business Wire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Business Wire
Datroway® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 13:00:00 CEST | Press release
Recommendation based on TROPION-Breast02 phase 3 trial where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival If approved, Datroway has potential to be the first TROP2 directed antibody drug conjugate for patients in EU with a demonstrated overall survival benefit as first-line treatment Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use
DAYBU®(trofinetide) Recommended for Approval in the European Union by CHMP26.6.2026 12:49:00 CEST | Press release
-- European Commission decision expected in the coming months-- If approved, DAYBU®would become the first treatment for neurobehavioral symptoms of Rett syndrome in the European Union Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-examination procedure, recommending the granting of a marketing authorization for DAYBU® (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older. If granted marketing authorization by the European Commission, DAYBU® would be the first therapy approved for this indication in the European Union (EU). “The CHMP’s positive opinion for DAYBU® is an important milestone in our mission to bring this innovative therapy to the EU, where there are no therapies specifically approved for the neurobehavioral symptoms of this devastating
HTEC Showcases Lakebase Branching at Databricks’ Data & AI Summit26.6.2026 11:18:00 CEST | Press release
HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. The Solution was developed in collaboration with a leading risk and compliance technology provider who serves financial institutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260626875859/en/ HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. Solving Critical Development Bottlenecks in Regulated Environments At the core of the collaboration was a shared challenge: how to enable modern data workflows in an envi
Stallergenes Greer Named One of Switzerland’s Best Managed Companies for 202626.6.2026 10:28:00 CEST | Press release
Stallergenes Greer, a global leader in allergy care, has been recognised for its overall business performance, company culture, and sustained growth by receiving the prestigious 2026 Switzerland’s Best Managed Companies award. The 2026 Best Managed Companies programme award winners are among Switzerland’s best private companies. The awards are derived from Deloitte’s global Best Managed Companies awards programme, an internationally recognised programme that evaluates businesses based on their leadership in the areas of strategy, culture and commitment, capabilities, innovation, governance and financial performance. Applicants are evaluated by an independent jury of experts. The evaluation of the Switzerland awards is based on more than 30 years of observed practice from the global awards programme that has been rolled out in 50+ countries worldwide. This recognition reflects Stallergenes Greer's consistent ability to deliver on its strategic vision while maintaining the operational di
Roboverse Reply Impresses at ELROB 2026 With Intelligent Robotic Systems for Critical Missions26.6.2026 10:00:00 CEST | Press release
Roboverse Reply, the Reply Group company specializing in robotics and automation, won the 1st Place in the “Reconnaissance” category and a special prize for “Best Team Effort” at the European Land Robot Trial (ELROB) 2026 in Thun, Switzerland. Teaming up with ELP, a specialist for technical equipment for defusing service, the company demonstrated outstanding performance alongside a field of international participants from June 15 to 19, proving that its autonomous solutions operate reliably under real-world conditions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260626012237/en/ Roboverse Reply won 1st Place in the “Reconnaissance” category and a special prize for “Best Team Effort” at the European Land Robot Trial 2026, proving that its autonomous solutions operate reliably under real-world conditions. ELROB is Europe’s most demanding and established showcase for robotics and unmanned systems, where leading experts from
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.
Besøg vores nyhedsrum
